Related references
Note: Only part of the references are listed.Relationship between Nonmedical Prescription-Opioid Use and Heroin Use
Wilson M. Compton et al.
NEW ENGLAND JOURNAL OF MEDICINE (2016)
Increases in Drug and Opioid Overdose Deaths - United States, 2000-2014
Rose A. Rudd et al.
MMWR-MORBIDITY AND MORTALITY WEEKLY REPORT (2016)
Short term health-related quality of life improvement during opioid agonist treatment
B. Nosyk et al.
DRUG AND ALCOHOL DEPENDENCE (2015)
Changes in Substance Abuse Treatment Use Among Individuals With Opioid Use Disorders in the United States. 2004-2013
Brendan Saloner et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2015)
Changes in Quality of Life following Buprenorphine Treatment: Relationship with Treatment Retention and Illicit Opioid Use
Shannon Gwin Mitchell et al.
JOURNAL OF PSYCHOACTIVE DRUGS (2015)
Treatment retention among patients randomized to buprenorphine/naloxone compared to methadone in a multi-site trial
Yih-Ing Hser et al.
ADDICTION (2014)
The impact of methadone maintenance therapy on hepatitis C incidence among illicit drug users
Seonaid Nolan et al.
ADDICTION (2014)
Determinants of the Availability of Hepatitis C Testing Services in Opioid Treatment Programs: Results From a National Study
Jemima A. Frimpong et al.
AMERICAN JOURNAL OF PUBLIC HEALTH (2014)
Emerging Epidemic of Hepatitis C Virus Infections Among Young Nonurban Persons Who Inject Drugs in the United States, 2006-2012
Anil G. Suryaprasad et al.
CLINICAL INFECTIOUS DISEASES (2014)
Opioid substitution therapy protects against hepatitis C virus acquisition in people who inject drugs: the HITS-c study
Bethany White et al.
MEDICAL JOURNAL OF AUSTRALIA (2014)
Medication-Assisted Treatment With Methadone: Assessing the Evidence
Catherine Anne Fullerton et al.
PSYCHIATRIC SERVICES (2014)
Primary Care-Based Buprenorphine Taper vs Maintenance Therapy for Prescription Opioid Dependence A Randomized Clinical Trial
David A. Fiellin et al.
JAMA INTERNAL MEDICINE (2014)
Association of Opioid Agonist Therapy With Lower Incidence of Hepatitis C Virus Infection in Young Adult Injection Drug Users
Judith I. Tsui et al.
JAMA INTERNAL MEDICINE (2014)
Medication-assisted treatment for opioid addiction: Methadone and buprenorphine
Andrew J. Saxon et al.
JOURNAL OF FOOD AND DRUG ANALYSIS (2013)
Patient Perspectives on Choosing Buprenorphine Over Methadone in an Urban, Equal-Access System
Jan Gryczynski et al.
AMERICAN JOURNAL ON ADDICTIONS (2013)
Receipt of opioid agonist treatment in the Veterans Health Administration: Facility and patient factors
Elizabeth M. Oliva et al.
DRUG AND ALCOHOL DEPENDENCE (2012)
Opiate substitution treatment and HIV transmission in people who inject drugs: systematic review and meta-analysis
Georgie J. MacArthur et al.
BMJ-BRITISH MEDICAL JOURNAL (2012)
Global epidemiology of hepatitis B and hepatitis C in people who inject drugs: results of systematic reviews
Paul K. Nelson et al.
LANCET (2011)
Barriers to Use of Pharmacotherapy for Addiction Disorders and How to Overcome Them
Elizabeth M. Oliva et al.
CURRENT PSYCHIATRY REPORTS (2011)
Patients' Reasons for Choosing Office-Based Buprenorphine: Preference for Patient-Centered Care
P. Todd Korthuis et al.
JOURNAL OF ADDICTION MEDICINE (2010)
Attribution of Hepatitis C Virus Seroconversion Risk in Young Injection Drug Users in 5 US Cities
Holly Hagan et al.
JOURNAL OF INFECTIOUS DISEASES (2010)
The SUMMIT Trial A field comparison of buprenorphine versus methadone maintenance treatment
Hayley Pinto et al.
JOURNAL OF SUBSTANCE ABUSE TREATMENT (2010)
Prevalence of hepatitis C virus infection among injection drug users in the United States, 1994-2004
Joseph J. Amon et al.
CLINICAL INFECTIOUS DISEASES (2008)
Global epidemiology of injecting drug use and HIV among people who inject drugs: a systematic review
Bradley M. Mathers et al.
LANCET (2008)
'Decreasing international HIV transmission: the role of expanding access to opioid agonist therapies for injection drug users
LE Sullivan et al.
ADDICTION (2005)
Share Paper
